Evidence map›Paper›PMID 24820099›Full record

ArticleScientific reports2014

Beyond Warburg effect--dual metabolic nature of cancer cells.

Jiansheng Xie, Hao Wu, Chunyan Dai, Qiangrong Pan, Zonghui Ding, Danqing Hu, Bingyan Ji, Yan Luo, Xun Hu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 124 papers.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 206 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. International journal of molecular medicine · 2026
    Review
  6. Review
  7. Metabolic Competition-Driven Antitumor Immunity ofCancer communications (London, England) · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. A Systemic View of Target Identification: Modeling the Warburg Effect.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  20. Article

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiansheng Xie1] Cancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital [2].
Hao Wu1] Cancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital [2].
Chunyan Dai1] Cancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital [2].
Qiangrong PanCancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital.
Zonghui DingCancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital.
Danqing HuCancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital.
Bingyan JiSchool of Basic Medical Sciences, Zhejiang University School of Medicine.
Yan LuoSchool of Basic Medical Sciences, Zhejiang University School of Medicine.
Xun HuCancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provincial Key Laboratory of Molecular Biology in Medical Sciences), the Second Affiliated Hospital.
Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Warburg effect is a dominant phenotype of most cancer cells. Here we show that this phenotype depends on its environment. When cancer cells are under regular culture condition, they show Warburg effect; whereas under lactic acidosis, they show a nonglycolytic phenotype, characterized by a high ratio of oxygen consumption rate over glycolytic rate, negligible lactate production and efficient incorporation of glucose carbon(s) into cellular mass. These two metabolic modes are intimately interrelated, for Warburg effect generates lactic acidosis that promotes a transition to a nonglycolytic mode. This dual metabolic nature confers growth advantage to cancer cells adapting to ever changing microenvironment.

Indexed as

Acidosis, LacticAnimalsBiological TransportCell Line, TumorCell ProliferationDisease Models, AnimalFemaleGene Expression Regulation, EnzymologicGlucoseGlycolysisHeterograftsHumansHydrogen-Ion ConcentrationLactic AcidMiceNADGlucoseLactic AcidNAD

Identifiers

PMID24820099
PMCPMC4018627
OpenAlexW1989962016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.